nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomilnacipran—Tension headache—Telbivudine—hepatitis B	0.0843	0.0945	CcSEcCtD
Levomilnacipran—Urinary hesitation—Lamivudine—hepatitis B	0.0201	0.0225	CcSEcCtD
Levomilnacipran—Chest discomfort—Telbivudine—hepatitis B	0.0165	0.0185	CcSEcCtD
Levomilnacipran—Rhabdomyolysis—Telbivudine—hepatitis B	0.0165	0.0185	CcSEcCtD
Levomilnacipran—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.0116	0.013	CcSEcCtD
Levomilnacipran—Migraine—Telbivudine—hepatitis B	0.0104	0.0117	CcSEcCtD
Levomilnacipran—Neutropenia—Entecavir—hepatitis B	0.0104	0.0117	CcSEcCtD
Levomilnacipran—Upper respiratory tract infection—Entecavir—hepatitis B	0.0104	0.0116	CcSEcCtD
Levomilnacipran—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00986	0.011	CcSEcCtD
Levomilnacipran—Haematuria—Entecavir—hepatitis B	0.00949	0.0106	CcSEcCtD
Levomilnacipran—Hepatobiliary disease—Entecavir—hepatitis B	0.00942	0.0106	CcSEcCtD
Levomilnacipran—Rhabdomyolysis—Lamivudine—hepatitis B	0.00931	0.0104	CcSEcCtD
Levomilnacipran—Haematuria—Adefovir Dipivoxil—hepatitis B	0.00926	0.0104	CcSEcCtD
Levomilnacipran—Abdominal distension—Telbivudine—hepatitis B	0.00923	0.0104	CcSEcCtD
Levomilnacipran—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00919	0.0103	CcSEcCtD
Levomilnacipran—Hepatitis—Entecavir—hepatitis B	0.00894	0.01	CcSEcCtD
Levomilnacipran—Oedema peripheral—Entecavir—hepatitis B	0.0088	0.00987	CcSEcCtD
Levomilnacipran—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00872	0.00977	CcSEcCtD
Levomilnacipran—Hypercholesterolaemia—Lamivudine—hepatitis B	0.00871	0.00976	CcSEcCtD
Levomilnacipran—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00861	0.00965	CcSEcCtD
Levomilnacipran—Neutropenia—Telbivudine—hepatitis B	0.00858	0.00961	CcSEcCtD
Levomilnacipran—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00857	0.00961	CcSEcCtD
Levomilnacipran—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00855	0.00958	CcSEcCtD
Levomilnacipran—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00852	0.00956	CcSEcCtD
Levomilnacipran—Mental disorder—Entecavir—hepatitis B	0.00783	0.00878	CcSEcCtD
Levomilnacipran—Malnutrition—Entecavir—hepatitis B	0.00778	0.00872	CcSEcCtD
Levomilnacipran—Hepatobiliary disease—Telbivudine—hepatitis B	0.00773	0.00867	CcSEcCtD
Levomilnacipran—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00759	0.00851	CcSEcCtD
Levomilnacipran—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00748	0.00838	CcSEcCtD
Levomilnacipran—Hepatitis—Telbivudine—hepatitis B	0.00734	0.00823	CcSEcCtD
Levomilnacipran—Hypoaesthesia—Telbivudine—hepatitis B	0.0073	0.00819	CcSEcCtD
Levomilnacipran—CYP2J2—Xenobiotics—CYP2A6—hepatitis B	0.00722	0.0802	CbGpPWpGaD
Levomilnacipran—Connective tissue disorder—Telbivudine—hepatitis B	0.00721	0.00809	CcSEcCtD
Levomilnacipran—Leukopenia—Entecavir—hepatitis B	0.00696	0.00781	CcSEcCtD
Levomilnacipran—Mediastinal disorder—Telbivudine—hepatitis B	0.00662	0.00742	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00658	0.00737	CcSEcCtD
Levomilnacipran—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00646	0.00724	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00642	0.00719	CcSEcCtD
Levomilnacipran—Malnutrition—Telbivudine—hepatitis B	0.00639	0.00716	CcSEcCtD
Levomilnacipran—Infection—Entecavir—hepatitis B	0.00631	0.00707	CcSEcCtD
Levomilnacipran—Thirst—Lamivudine—hepatitis B	0.00628	0.00704	CcSEcCtD
Levomilnacipran—Dysgeusia—Telbivudine—hepatitis B	0.00626	0.00702	CcSEcCtD
Levomilnacipran—Nervous system disorder—Entecavir—hepatitis B	0.00623	0.00698	CcSEcCtD
Levomilnacipran—Skin disorder—Entecavir—hepatitis B	0.00617	0.00691	CcSEcCtD
Levomilnacipran—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00608	0.00681	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00607	0.0068	CcSEcCtD
Levomilnacipran—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00602	0.00675	CcSEcCtD
Levomilnacipran—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00591	0.00662	CcSEcCtD
Levomilnacipran—Migraine—Lamivudine—hepatitis B	0.00589	0.0066	CcSEcCtD
Levomilnacipran—Insomnia—Entecavir—hepatitis B	0.00574	0.00644	CcSEcCtD
Levomilnacipran—Somnolence—Entecavir—hepatitis B	0.00564	0.00633	CcSEcCtD
Levomilnacipran—Dyspepsia—Entecavir—hepatitis B	0.00559	0.00627	CcSEcCtD
Levomilnacipran—Liver function test abnormal—Lamivudine—hepatitis B	0.00552	0.00619	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Entecavir—hepatitis B	0.00548	0.00614	CcSEcCtD
Levomilnacipran—Fatigue—Entecavir—hepatitis B	0.00547	0.00614	CcSEcCtD
Levomilnacipran—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00545	0.00611	CcSEcCtD
Levomilnacipran—Chest pain—Telbivudine—hepatitis B	0.00544	0.0061	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.0054	0.00606	CcSEcCtD
Levomilnacipran—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00539	0.00604	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00535	0.006	CcSEcCtD
Levomilnacipran—Abdominal distension—Lamivudine—hepatitis B	0.0052	0.00583	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Entecavir—hepatitis B	0.00519	0.00582	CcSEcCtD
Levomilnacipran—Nervous system disorder—Telbivudine—hepatitis B	0.00512	0.00573	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Telbivudine—hepatitis B	0.00511	0.00572	CcSEcCtD
Levomilnacipran—Skin disorder—Telbivudine—hepatitis B	0.00507	0.00568	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00507	0.00568	CcSEcCtD
Levomilnacipran—Abdominal pain—Entecavir—hepatitis B	0.00502	0.00563	CcSEcCtD
Levomilnacipran—Body temperature increased—Entecavir—hepatitis B	0.00502	0.00563	CcSEcCtD
Levomilnacipran—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.0049	0.00549	CcSEcCtD
Levomilnacipran—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.0049	0.00549	CcSEcCtD
Levomilnacipran—Dysuria—Lamivudine—hepatitis B	0.00483	0.00542	CcSEcCtD
Levomilnacipran—Neutropenia—Lamivudine—hepatitis B	0.00483	0.00542	CcSEcCtD
Levomilnacipran—Pollakiuria—Lamivudine—hepatitis B	0.00478	0.00535	CcSEcCtD
Levomilnacipran—Insomnia—Telbivudine—hepatitis B	0.00472	0.00529	CcSEcCtD
Levomilnacipran—Paraesthesia—Telbivudine—hepatitis B	0.00468	0.00525	CcSEcCtD
Levomilnacipran—Dyspepsia—Telbivudine—hepatitis B	0.00459	0.00515	CcSEcCtD
Levomilnacipran—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00457	0.00512	CcSEcCtD
Levomilnacipran—Asthenia—Entecavir—hepatitis B	0.00456	0.00511	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Telbivudine—hepatitis B	0.0045	0.00505	CcSEcCtD
Levomilnacipran—Fatigue—Telbivudine—hepatitis B	0.0045	0.00504	CcSEcCtD
Levomilnacipran—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00444	0.00498	CcSEcCtD
Levomilnacipran—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00438	0.00491	CcSEcCtD
Levomilnacipran—Hepatobiliary disease—Lamivudine—hepatitis B	0.00436	0.00489	CcSEcCtD
Levomilnacipran—Diarrhoea—Entecavir—hepatitis B	0.00434	0.00487	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Telbivudine—hepatitis B	0.00427	0.00478	CcSEcCtD
Levomilnacipran—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00424	0.00475	CcSEcCtD
Levomilnacipran—Dizziness—Entecavir—hepatitis B	0.0042	0.00471	CcSEcCtD
Levomilnacipran—Hepatitis—Lamivudine—hepatitis B	0.00414	0.00464	CcSEcCtD
Levomilnacipran—Body temperature increased—Telbivudine—hepatitis B	0.00412	0.00462	CcSEcCtD
Levomilnacipran—Abdominal pain—Telbivudine—hepatitis B	0.00412	0.00462	CcSEcCtD
Levomilnacipran—Hypoaesthesia—Lamivudine—hepatitis B	0.00412	0.00461	CcSEcCtD
Levomilnacipran—Connective tissue disorder—Lamivudine—hepatitis B	0.00407	0.00456	CcSEcCtD
Levomilnacipran—Vomiting—Entecavir—hepatitis B	0.00404	0.00453	CcSEcCtD
Levomilnacipran—Rash—Entecavir—hepatitis B	0.004	0.00449	CcSEcCtD
Levomilnacipran—Dermatitis—Entecavir—hepatitis B	0.004	0.00448	CcSEcCtD
Levomilnacipran—Headache—Entecavir—hepatitis B	0.00398	0.00446	CcSEcCtD
Levomilnacipran—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00394	0.00442	CcSEcCtD
Levomilnacipran—Erythema multiforme—Lamivudine—hepatitis B	0.00391	0.00439	CcSEcCtD
Levomilnacipran—Rash—Adefovir Dipivoxil—hepatitis B	0.00391	0.00438	CcSEcCtD
Levomilnacipran—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.0039	0.00437	CcSEcCtD
Levomilnacipran—Headache—Adefovir Dipivoxil—hepatitis B	0.00388	0.00435	CcSEcCtD
Levomilnacipran—Nausea—Entecavir—hepatitis B	0.00377	0.00423	CcSEcCtD
Levomilnacipran—Asthenia—Telbivudine—hepatitis B	0.00374	0.0042	CcSEcCtD
Levomilnacipran—Mediastinal disorder—Lamivudine—hepatitis B	0.00373	0.00418	CcSEcCtD
Levomilnacipran—Chills—Lamivudine—hepatitis B	0.00371	0.00416	CcSEcCtD
Levomilnacipran—Pruritus—Telbivudine—hepatitis B	0.00369	0.00414	CcSEcCtD
Levomilnacipran—Nausea—Adefovir Dipivoxil—hepatitis B	0.00368	0.00412	CcSEcCtD
Levomilnacipran—Malnutrition—Lamivudine—hepatitis B	0.0036	0.00404	CcSEcCtD
Levomilnacipran—Diarrhoea—Telbivudine—hepatitis B	0.00357	0.004	CcSEcCtD
Levomilnacipran—Flatulence—Lamivudine—hepatitis B	0.00355	0.00398	CcSEcCtD
Levomilnacipran—Tension—Lamivudine—hepatitis B	0.00353	0.00396	CcSEcCtD
Levomilnacipran—Dysgeusia—Lamivudine—hepatitis B	0.00353	0.00395	CcSEcCtD
Levomilnacipran—Dizziness—Telbivudine—hepatitis B	0.00345	0.00387	CcSEcCtD
Levomilnacipran—Tremor—Lamivudine—hepatitis B	0.00337	0.00378	CcSEcCtD
Levomilnacipran—Vomiting—Telbivudine—hepatitis B	0.00332	0.00372	CcSEcCtD
Levomilnacipran—Rash—Telbivudine—hepatitis B	0.00329	0.00369	CcSEcCtD
Levomilnacipran—Dermatitis—Telbivudine—hepatitis B	0.00329	0.00368	CcSEcCtD
Levomilnacipran—Headache—Telbivudine—hepatitis B	0.00327	0.00366	CcSEcCtD
Levomilnacipran—Syncope—Lamivudine—hepatitis B	0.00323	0.00362	CcSEcCtD
Levomilnacipran—Leukopenia—Lamivudine—hepatitis B	0.00322	0.00361	CcSEcCtD
Levomilnacipran—Loss of consciousness—Lamivudine—hepatitis B	0.00317	0.00355	CcSEcCtD
Levomilnacipran—Convulsion—Lamivudine—hepatitis B	0.00312	0.0035	CcSEcCtD
Levomilnacipran—Nausea—Telbivudine—hepatitis B	0.0031	0.00347	CcSEcCtD
Levomilnacipran—Chest pain—Lamivudine—hepatitis B	0.00307	0.00344	CcSEcCtD
Levomilnacipran—Anxiety—Lamivudine—hepatitis B	0.00306	0.00343	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00305	0.00341	CcSEcCtD
Levomilnacipran—CYP2J2—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.003	0.0333	CbGpPWpGaD
Levomilnacipran—Dry mouth—Lamivudine—hepatitis B	0.003	0.00336	CcSEcCtD
Levomilnacipran—CYP2J2—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.00296	0.0329	CbGpPWpGaD
Levomilnacipran—Infection—Lamivudine—hepatitis B	0.00292	0.00327	CcSEcCtD
Levomilnacipran—CYP2C8—CYP2E1 reactions—CYP2A6—hepatitis B	0.00291	0.0323	CbGpPWpGaD
Levomilnacipran—Shock—Lamivudine—hepatitis B	0.00289	0.00324	CcSEcCtD
Levomilnacipran—Nervous system disorder—Lamivudine—hepatitis B	0.00288	0.00323	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Lamivudine—hepatitis B	0.00288	0.00323	CcSEcCtD
Levomilnacipran—Skin disorder—Lamivudine—hepatitis B	0.00286	0.0032	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Lamivudine—hepatitis B	0.00284	0.00319	CcSEcCtD
Levomilnacipran—Anorexia—Lamivudine—hepatitis B	0.0028	0.00314	CcSEcCtD
Levomilnacipran—Hypotension—Lamivudine—hepatitis B	0.00275	0.00308	CcSEcCtD
Levomilnacipran—CYP2J2—Arachidonic acid metabolism—GGT1—hepatitis B	0.00271	0.0301	CbGpPWpGaD
Levomilnacipran—SLC6A4—blood plasma—hepatitis B	0.00269	0.151	CbGeAlD
Levomilnacipran—Insomnia—Lamivudine—hepatitis B	0.00266	0.00298	CcSEcCtD
Levomilnacipran—Paraesthesia—Lamivudine—hepatitis B	0.00264	0.00296	CcSEcCtD
Levomilnacipran—Dyspnoea—Lamivudine—hepatitis B	0.00262	0.00294	CcSEcCtD
Levomilnacipran—Somnolence—Lamivudine—hepatitis B	0.00261	0.00293	CcSEcCtD
Levomilnacipran—CYP2C19—CYP2E1 reactions—CYP2A6—hepatitis B	0.0026	0.0288	CbGpPWpGaD
Levomilnacipran—Dyspepsia—Lamivudine—hepatitis B	0.00259	0.0029	CcSEcCtD
Levomilnacipran—Decreased appetite—Lamivudine—hepatitis B	0.00256	0.00286	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00254	0.00284	CcSEcCtD
Levomilnacipran—Fatigue—Lamivudine—hepatitis B	0.00253	0.00284	CcSEcCtD
Levomilnacipran—Constipation—Lamivudine—hepatitis B	0.00251	0.00282	CcSEcCtD
Levomilnacipran—CYP2J2—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.00243	0.027	CbGpPWpGaD
Levomilnacipran—Gastrointestinal pain—Lamivudine—hepatitis B	0.0024	0.00269	CcSEcCtD
Levomilnacipran—CYP2D6—CYP2E1 reactions—CYP2A6—hepatitis B	0.00239	0.0265	CbGpPWpGaD
Levomilnacipran—Urticaria—Lamivudine—hepatitis B	0.00234	0.00262	CcSEcCtD
Levomilnacipran—Abdominal pain—Lamivudine—hepatitis B	0.00232	0.0026	CcSEcCtD
Levomilnacipran—Body temperature increased—Lamivudine—hepatitis B	0.00232	0.0026	CcSEcCtD
Levomilnacipran—CYP2C19—blood plasma—hepatitis B	0.00223	0.125	CbGeAlD
Levomilnacipran—CYP2J2—Metapathway biotransformation—AKR1B1—hepatitis B	0.00219	0.0244	CbGpPWpGaD
Levomilnacipran—Hypersensitivity—Lamivudine—hepatitis B	0.00217	0.00243	CcSEcCtD
Levomilnacipran—CYP2J2—Biological oxidations—GGT2—hepatitis B	0.00213	0.0237	CbGpPWpGaD
Levomilnacipran—Asthenia—Lamivudine—hepatitis B	0.00211	0.00236	CcSEcCtD
Levomilnacipran—Pruritus—Lamivudine—hepatitis B	0.00208	0.00233	CcSEcCtD
Levomilnacipran—Diarrhoea—Lamivudine—hepatitis B	0.00201	0.00225	CcSEcCtD
Levomilnacipran—CYP2C8—blood plasma—hepatitis B	0.00195	0.109	CbGeAlD
Levomilnacipran—Dizziness—Lamivudine—hepatitis B	0.00194	0.00218	CcSEcCtD
Levomilnacipran—Vomiting—Lamivudine—hepatitis B	0.00187	0.0021	CcSEcCtD
Levomilnacipran—Rash—Lamivudine—hepatitis B	0.00185	0.00208	CcSEcCtD
Levomilnacipran—Dermatitis—Lamivudine—hepatitis B	0.00185	0.00208	CcSEcCtD
Levomilnacipran—Headache—Lamivudine—hepatitis B	0.00184	0.00206	CcSEcCtD
Levomilnacipran—CYP2C8—Xenobiotics—CYP2A6—hepatitis B	0.0018	0.02	CbGpPWpGaD
Levomilnacipran—CYP2D6—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.00177	0.0197	CbGpPWpGaD
Levomilnacipran—Nausea—Lamivudine—hepatitis B	0.00175	0.00196	CcSEcCtD
Levomilnacipran—CYP2C8—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00173	0.0193	CbGpPWpGaD
Levomilnacipran—CYP3A4—Aflatoxin activation and detoxification—GGT2—hepatitis B	0.00166	0.0185	CbGpPWpGaD
Levomilnacipran—CYP2C19—Xenobiotics—CYP2A6—hepatitis B	0.00161	0.0179	CbGpPWpGaD
Levomilnacipran—CYP2C19—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00155	0.0172	CbGpPWpGaD
Levomilnacipran—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—hepatitis B	0.00155	0.0172	CbGpPWpGaD
Levomilnacipran—CYP2D6—Xenobiotics—CYP2A6—hepatitis B	0.00148	0.0164	CbGpPWpGaD
Levomilnacipran—CYP2J2—liver—hepatitis B	0.00143	0.08	CbGeAlD
Levomilnacipran—CYP2D6—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00142	0.0158	CbGpPWpGaD
Levomilnacipran—SLC6A4—NRF2 pathway—GGT2—hepatitis B	0.0014	0.0155	CbGpPWpGaD
Levomilnacipran—CYP3A4—blood plasma—hepatitis B	0.00132	0.0737	CbGeAlD
Levomilnacipran—CYP2D6—blood plasma—hepatitis B	0.0013	0.0726	CbGeAlD
Levomilnacipran—CYP2J2—Biological oxidations—CYP2A6—hepatitis B	0.00129	0.0143	CbGpPWpGaD
Levomilnacipran—SLC6A2—NRF2 pathway—GGT2—hepatitis B	0.0012	0.0133	CbGpPWpGaD
Levomilnacipran—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—hepatitis B	0.00116	0.0128	CbGpPWpGaD
Levomilnacipran—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.0011	0.0123	CbGpPWpGaD
Levomilnacipran—ABCB1—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.00108	0.012	CbGpPWpGaD
Levomilnacipran—CYP2J2—Biological oxidations—GGT1—hepatitis B	0.00101	0.0112	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—HLA-DPA1—hepatitis B	0.000996	0.0111	CbGpPWpGaD
Levomilnacipran—SLC6A4—blood—hepatitis B	0.000986	0.0551	CbGeAlD
Levomilnacipran—CYP3A4—Xenobiotics—CYP2A6—hepatitis B	0.000968	0.0107	CbGpPWpGaD
Levomilnacipran—ABCB1—blood plasma—hepatitis B	0.000934	0.0522	CbGeAlD
Levomilnacipran—CYP3A4—Tamoxifen metabolism—CYP2A6—hepatitis B	0.000931	0.0103	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000854	0.00948	CbGpPWpGaD
Levomilnacipran—SLC6A4—NRF2 pathway—CYP2A6—hepatitis B	0.000846	0.00939	CbGpPWpGaD
Levomilnacipran—CYP2C19—blood—hepatitis B	0.000817	0.0457	CbGeAlD
Levomilnacipran—CYP3A4—Aflatoxin activation and detoxification—GGT1—hepatitis B	0.000787	0.00874	CbGpPWpGaD
Levomilnacipran—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000749	0.00831	CbGpPWpGaD
Levomilnacipran—CYP2C8—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000739	0.00821	CbGpPWpGaD
Levomilnacipran—SLC6A2—NRF2 pathway—CYP2A6—hepatitis B	0.000727	0.00808	CbGpPWpGaD
Levomilnacipran—CYP2C8—blood—hepatitis B	0.000713	0.0399	CbGeAlD
Levomilnacipran—SLC6A4—Monoamine Transport—TNF—hepatitis B	0.000698	0.00776	CbGpPWpGaD
Levomilnacipran—CYP2C8—Arachidonic acid metabolism—GGT1—hepatitis B	0.000676	0.00751	CbGpPWpGaD
Levomilnacipran—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000668	0.00742	CbGpPWpGaD
Levomilnacipran—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000664	0.00738	CbGpPWpGaD
Levomilnacipran—SLC6A4—NRF2 pathway—GGT1—hepatitis B	0.00066	0.00733	CbGpPWpGaD
Levomilnacipran—CYP2C19—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000659	0.00732	CbGpPWpGaD
Levomilnacipran—ABCB1—HIF-1-alpha transcription factor network—HNF4A—hepatitis B	0.000643	0.00714	CbGpPWpGaD
Levomilnacipran—CYP2C19—liver—hepatitis B	0.000639	0.0357	CbGeAlD
Levomilnacipran—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000615	0.00683	CbGpPWpGaD
Levomilnacipran—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000607	0.00674	CbGpPWpGaD
Levomilnacipran—CYP2D6—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000607	0.00674	CbGpPWpGaD
Levomilnacipran—CYP2C19—Arachidonic acid metabolism—GGT1—hepatitis B	0.000604	0.0067	CbGpPWpGaD
Levomilnacipran—SLC6A2—Monoamine Transport—TNF—hepatitis B	0.000601	0.00667	CbGpPWpGaD
Levomilnacipran—SLC6A2—NRF2 pathway—GGT1—hepatitis B	0.000568	0.0063	CbGpPWpGaD
Levomilnacipran—CYP2C8—liver—hepatitis B	0.000558	0.0312	CbGeAlD
Levomilnacipran—CYP2C8—Metapathway biotransformation—AKR1B1—hepatitis B	0.000547	0.00608	CbGpPWpGaD
Levomilnacipran—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000542	0.00602	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—GGT2—hepatitis B	0.000532	0.00591	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—IL10—hepatitis B	0.000517	0.00574	CbGpPWpGaD
Levomilnacipran—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000498	0.00553	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metapathway biotransformation—AKR1B1—hepatitis B	0.000489	0.00543	CbGpPWpGaD
Levomilnacipran—CYP3A4—blood—hepatitis B	0.000483	0.027	CbGeAlD
Levomilnacipran—CYP2D6—blood—hepatitis B	0.000476	0.0266	CbGeAlD
Levomilnacipran—CYP2C19—Biological oxidations—GGT2—hepatitis B	0.000475	0.00528	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—HLA-DPB1—hepatitis B	0.000457	0.00508	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metapathway biotransformation—AKR1B1—hepatitis B	0.000449	0.00499	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—GGT2—hepatitis B	0.000437	0.00485	CbGpPWpGaD
Levomilnacipran—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000402	0.00446	CbGpPWpGaD
Levomilnacipran—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000397	0.0044	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000387	0.0043	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—AKR1B1—hepatitis B	0.00038	0.00422	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—FAS—hepatitis B	0.000378	0.0042	CbGpPWpGaD
Levomilnacipran—CYP3A4—liver—hepatitis B	0.000378	0.0211	CbGeAlD
Levomilnacipran—CYP2C19—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000377	0.00419	CbGpPWpGaD
Levomilnacipran—CYP2D6—liver—hepatitis B	0.000372	0.0208	CbGeAlD
Levomilnacipran—CYP2J2—Metabolism—GGT2—hepatitis B	0.000365	0.00405	CbGpPWpGaD
Levomilnacipran—CYP2D6—Melatonin metabolism and effects—NFKB1—hepatitis B	0.000347	0.00385	CbGpPWpGaD
Levomilnacipran—ABCB1—blood—hepatitis B	0.000342	0.0191	CbGeAlD
Levomilnacipran—ABCB1—Allograft Rejection—CD40LG—hepatitis B	0.000337	0.00375	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—IL10—hepatitis B	0.000337	0.00375	CbGpPWpGaD
Levomilnacipran—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000326	0.00362	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—NOS2—hepatitis B	0.000324	0.00359	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—CYP2A6—hepatitis B	0.000322	0.00358	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—FASLG—hepatitis B	0.000314	0.00348	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—FAS—hepatitis B	0.000302	0.00336	CbGpPWpGaD
Levomilnacipran—ABCB1—HIF-1-alpha transcription factor network—NOS2—hepatitis B	0.000299	0.00332	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—HLA-A—hepatitis B	0.000297	0.0033	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metapathway biotransformation—AKR1B1—hepatitis B	0.000294	0.00326	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—CYP2A6—hepatitis B	0.000288	0.0032	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—GGT2—hepatitis B	0.000286	0.00317	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.000275	0.00305	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—HLA-DRB1—hepatitis B	0.000272	0.00302	CbGpPWpGaD
Levomilnacipran—ABCB1—liver—hepatitis B	0.000267	0.015	CbGeAlD
Levomilnacipran—CYP2D6—Biological oxidations—CYP2A6—hepatitis B	0.000265	0.00294	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	0.000261	0.0029	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—NFKB1—hepatitis B	0.000253	0.00281	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—GGT1—hepatitis B	0.000252	0.0028	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—GGT1—hepatitis B	0.000225	0.00249	CbGpPWpGaD
Levomilnacipran—SLC6A4—NRF2 pathway—TGFB1—hepatitis B	0.000222	0.00247	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—CYP2A6—hepatitis B	0.000221	0.00245	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000213	0.00237	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—PTEN—hepatitis B	0.000207	0.0023	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—GGT1—hepatitis B	0.000207	0.00229	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000206	0.00229	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—GOT2—hepatitis B	0.0002	0.00222	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—IFNG—hepatitis B	0.000198	0.0022	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—TNF—hepatitis B	0.000197	0.00218	CbGpPWpGaD
Levomilnacipran—SLC6A2—NRF2 pathway—TGFB1—hepatitis B	0.000191	0.00212	CbGpPWpGaD
Levomilnacipran—SLC6A2—SLC-mediated transmembrane transport—ALB—hepatitis B	0.00019	0.00211	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.00019	0.00211	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—IL2—hepatitis B	0.000176	0.00196	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—CYP2A6—hepatitis B	0.000173	0.00192	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—GGT1—hepatitis B	0.000172	0.00191	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—GOT1—hepatitis B	0.000172	0.00191	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—IL6—hepatitis B	0.000159	0.00176	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.000157	0.00174	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.000155	0.00172	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.000149	0.00166	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—TP53—hepatitis B	0.000142	0.00157	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—TGFB1—hepatitis B	0.000137	0.00153	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—GGT1—hepatitis B	0.000135	0.0015	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—IL6—hepatitis B	0.00013	0.00144	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—TNF—hepatitis B	0.000128	0.00143	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—ALB—hepatitis B	9.67e-05	0.00107	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	9.66e-05	0.00107	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—AKR1B1—hepatitis B	9.49e-05	0.00105	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—ALB—hepatitis B	9.17e-05	0.00102	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GGT2—hepatitis B	9.1e-05	0.00101	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	8.63e-05	0.000958	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—AKR1B1—hepatitis B	8.47e-05	0.000941	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	8.4e-05	0.000932	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—AKR1B1—hepatitis B	8.27e-05	0.000918	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	8.2e-05	0.000911	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	8.18e-05	0.000909	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	8.14e-05	0.000904	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GGT2—hepatitis B	8.12e-05	0.000902	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GGT2—hepatitis B	7.93e-05	0.00088	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—AKR1B1—hepatitis B	7.79e-05	0.000865	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GGT2—hepatitis B	7.47e-05	0.00083	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PTEN—hepatitis B	7e-05	0.000777	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	6.78e-05	0.000753	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	6.33e-05	0.000704	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	5.58e-05	0.00062	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CYP2A6—hepatitis B	5.51e-05	0.000612	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hepatitis B	5.14e-05	0.000571	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—AKR1B1—hepatitis B	5.09e-05	0.000566	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GOT2—hepatitis B	4.99e-05	0.000554	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CYP2A6—hepatitis B	4.92e-05	0.000547	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GGT2—hepatitis B	4.88e-05	0.000542	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CYP2A6—hepatitis B	4.8e-05	0.000533	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hepatitis B	4.59e-05	0.00051	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CYP2A6—hepatitis B	4.53e-05	0.000503	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GOT2—hepatitis B	4.45e-05	0.000494	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GOT2—hepatitis B	4.34e-05	0.000482	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GOT1—hepatitis B	4.3e-05	0.000478	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GGT1—hepatitis B	4.3e-05	0.000478	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—ALB—hepatitis B	4.26e-05	0.000473	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GOT2—hepatitis B	4.09e-05	0.000455	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	3.92e-05	0.000436	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GGT1—hepatitis B	3.84e-05	0.000427	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GOT1—hepatitis B	3.84e-05	0.000427	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GGT1—hepatitis B	3.75e-05	0.000416	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GOT1—hepatitis B	3.75e-05	0.000416	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GGT1—hepatitis B	3.53e-05	0.000392	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GOT1—hepatitis B	3.53e-05	0.000392	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	3.5e-05	0.000389	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CYP2A6—hepatitis B	2.96e-05	0.000329	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GOT2—hepatitis B	2.68e-05	0.000297	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GGT1—hepatitis B	2.31e-05	0.000257	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GOT1—hepatitis B	2.31e-05	0.000257	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ALB—hepatitis B	2.29e-05	0.000254	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ALB—hepatitis B	2.04e-05	0.000227	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ALB—hepatitis B	1.99e-05	0.000222	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ALB—hepatitis B	1.88e-05	0.000209	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PTEN—hepatitis B	1.75e-05	0.000194	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PTEN—hepatitis B	1.56e-05	0.000173	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PTEN—hepatitis B	1.52e-05	0.000169	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PTEN—hepatitis B	1.43e-05	0.000159	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ALB—hepatitis B	1.23e-05	0.000136	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PTEN—hepatitis B	9.38e-06	0.000104	CbGpPWpGaD
